| DGAT-1 inhibitor | IC50 | 15.0 [1] |
| PF-04620110 | IC50 | 19.0 [1] |
| CID 42636350 | IC50 | 10.0 [1], 70.0 [2], 80.0 [3], 430.0 [4] |
| 2-[4-[4-[[5-(3,4-Difluoroanilino)-1,3,4-oxadiazole-2-carbonyl]amino]phenyl]cyclohexyl]acetic acid | IC50 | 0.5 [1], 0.6 [2], 2.0 [3], 36.0 [4] |
| 2-[4-[4-[(5-Benzyl-1,3,4-thiadiazol-2-yl)carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 29.0 [1], 36.0 [2], 578.0 [3] |
| CID 24768261 | IC50 | 7.0 [1], 7.8 [2], 20.0 [3] |
| N-[6-[2-Methoxyethyl(methyl)amino]pyridin-3-yl]-2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carboxamide | IC50 | 38.0 [1] |
| 2-[4-[4-[[5-[(4-Fluorophenyl)methyl]-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 130.0 [1], 131.0 [2], 600.0 [3] |
| 4-[4-[[5-[(3,5-Difluorophenyl)methyl]-1,3,4-thiadiazol-2-yl]carbamoyl]phenoxy]cyclohexane-1-carboxylic acid | IC50 | 11.0 [1], 13.0 [2], 76.0 [3], 160.0 [4] |
| 4-[5-[5-(6-Fluoro-1H-benzimidazol-2-yl)pyridin-2-yl]pyridin-2-yl]oxycyclohexane-1-carboxylic acid | IC50 | 2.0 [1], 2.5 [2], 10000.0 [3] |
| 4-[5-[5-[6-(Trifluoromethyl)-1H-benzimidazol-2-yl]pyridin-2-yl]pyridin-2-yl]oxycyclohexane-1-carboxylic acid | IC50 | 1.7 [1], 3.0 [2], 1093.0 [3], 1232.0 [4] |
| 4-[5-[5-(6-Chloro-1H-benzimidazol-2-yl)pyridin-2-yl]pyridin-2-yl]oxycyclohexane-1-carboxylic acid | IC50 | 2.0 [1], 2.1 [2], 1344.0 [3], 3528.0 [4] |
| 4-[5-[5-(1H-Benzimidazol-2-yl)pyridin-2-yl]pyridin-2-yl]oxycyclohexane-1-carboxylic acid | IC50 | 4.0 [1], 5.3 [2], 6065.0 [3], 8080.0 [4] |
| 4-[5-[5-(5,6-Difluoro-1H-benzimidazol-2-yl)pyridin-2-yl]pyridin-2-yl]oxycyclohexane-1-carboxylic acid | IC50 | 1.3 [1], 1.4 [2], 8440.0 [3], 10000.0 [4] |
| 4-[5-[5-(6-Cyano-1H-benzimidazol-2-yl)pyridin-2-yl]pyridin-2-yl]oxycyclohexane-1-carboxylic acid | IC50 | 3.2 [1], 6.0 [2], 10000.0 [3] |
| 4-[5-[5-(6-Methylsulfonyl-1H-benzimidazol-2-yl)pyridin-2-yl]pyridin-2-yl]oxycyclohexane-1-carboxylic acid | IC50 | 101.0 [1], 137.0 [2], 10000.0 [3] |
| 4-[5-[5-(5-Methyl-1H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-yl]pyridin-2-yl]oxycyclohexane-1-carboxylic acid | IC50 | 32.0 [1], 54.0 [2], 8782.0 [3], 10000.0 [4] |
| 4-[5-[5-(5-Methoxy-1H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-yl]pyridin-2-yl]oxycyclohexane-1-carboxylic acid | IC50 | 11.0 [1], 14.0 [2], 2475.0 [3], 4903.0 [4] |
| 4-[4-[4-[[2-Phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]phenyl]piperidine-1-carbonyl]cyclohexane-1-carboxylic acid | IC50 | 57.0 [1], 82.0 [2], 114.0 [3] |
| 2-[4-[4-[4-(Phenylcarbamoyl)-2,3-dihydro-1,4-benzoxazin-7-yl]phenyl]cyclohexyl]acetic acid | IC50 | 52.0 [1], 65.0 [2] |
| 4-[4-[2-(Naphthalene-2-carbonylamino)ethylcarbamoyl]phenoxy]adamantane-1-carboxylic acid | IC50 | 34.0 [1], 44.0 [2], 48.0 [3] |
| 4-[4-[2-[(4-Phenylbenzoyl)amino]ethylcarbamoyl]phenoxy]adamantane-1-carboxylic acid | IC50 | 5.0 [1], 12.0 [2], 25.0 [3] |
| 4-[4-[(5-Benzyl-1,3,4-thiadiazol-2-yl)carbamoyl]phenoxy]cyclohexane-1-carboxylic acid | IC50 | 16.0 [1], 28.0 [2], 280.0 [3] |
| CID 49846226 | IC50 | 3.98 [1], 7.94 [2] |
| 2-(4'-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)-2-chlorobiphenyl-4-yl)acetic acid | IC50 | 6.31 [1] |
| 3-[4-[4-(4-Amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6-yl)phenyl]cyclohexyl]propanoic acid | IC50 | 31.0 [1], 31.62 [2], 131.0 [3] |
| Unii-G3MY6fge1J | IC50 | 3.0 [1], 4.0 [2] |
| 2-(trans-4-(4-(7-Aminopyrazolo[1,5-a]pyrimidin-6-yl)phenyl)cyclohexyl)acetic acid | IC50 | 8.0 [1], 78.0 [2] |
| (1R,2R)-2-[4-[3-Fluoro-4-[(6-fluoro-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid | IC50 | 73.0 [1] |
| 2-[4-[4-[1-(Phenylcarbamoyl)indol-5-yl]phenyl]cyclohexyl]acetic acid | IC50 | 37.0 [1] |
| 1-Methylsulfonyl-1'-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]pyridin-2-yl]spiro[2H-indole-3,4'-piperidine] | IC50 | 68.0 [1] |
| 1'-[5-(6-Chloro-1H-benzimidazol-2-yl)pyridin-2-yl]spiro[2-benzofuran-3,4'-piperidine]-1-one | IC50 | 52.0 [1] |
| 4-[1-[5-[6-(Trifluoromethyl)-1H-benzimidazol-2-yl]pyridin-2-yl]piperidin-4-yl]oxycyclohexane-1-carboxylic acid | IC50 | 2.5 [1], 3.9 [2] |
| 2-[4-[4-(4-Amino-2,7,7-trimethylpyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]cyclohexyl]acetic acid | IC50 | 8.0 [1], 30.0 [2] |
| 2-[6-(4-Amino-7,7-dimethylpyrano[2,3-d]pyrimidin-6-yl)spiro[1,2-dihydroindene-3,4'-cyclohexane]-1'-yl]acetic acid | IC50 | 9.0 [1], 13.0 [2] |
| 2-[4-[4-(4-Amino-7,7-dimethylpyrano[2,3-d]pyrimidin-6-yl)phenyl]cyclohexyl]acetic acid | IC50 | 8.0 [1], 50.0 [2] |
| 2-[(2R)-2-Ethyl-1-oxo-6-[4-[[3-(trifluoromethyl)phenyl]carbamoylamino]phenyl]-3,4-dihydronaphthalen-2-yl]acetic acid | IC50 | 126.0 [1], 251.0 [2] |
| 4-[4-[(5-Anilino-1,3,4-thiadiazol-2-yl)carbamoyl]phenoxy]cyclohexane-1-carboxylic acid | IC50 | 3.0 [1], 4.0 [2] |
| 2-[(2S)-6-[4-[(4-Chlorophenyl)carbamoylamino]phenyl]-2-ethyl-1-oxo-3,4-dihydronaphthalen-2-yl]acetic acid | IC50 | 2.0 [1], 8.0 [2] |
| 4-[4-[4-[[2-Phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]phenyl]piperazine-1-carbonyl]cyclohexane-1-carboxylic acid | IC50 | 77.0 [1], 277.0 [2] |
| 2-[4-[4-(4-Amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6-yl)phenyl]cyclohexyl]acetonitrile | IC50 | 41.0 [1], 64.0 [2] |
| 6-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)spiro[1,2-dihydroindene-3,4'-cyclohexane]-1'-carboxylic acid | IC50 | 170.0 [1], 240.0 [2] |
| 2-[4-[4-[[5-(2-Phenylethyl)-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 70.0 [1], 590.0 [2] |
| 2-[4-[4-[[5-[2-(4-Fluorophenyl)ethyl]-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 66.0 [1], 173.0 [2] |
| 2-[4-[4-[[5-[3-(4-Fluorophenyl)propyl]-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 50.0 [1], 181.0 [2] |
| 2-[4-[4-[[5-[(4-Fluorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 44.0 [1], 91.0 [2] |
| 2-[4-[4-[[5-(Cyclopentylmethyl)-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 24.0 [1], 33.0 [2] |
| 2-[4-[4-[[5-(Cyclopentyloxymethyl)-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 38.0 [1], 66.0 [2] |
| 4-Amino-6-(4-tert-butylphenyl)-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one | IC50 | 43.0 [1], 134.0 [2] |
| 2-[4-[4-(4-Amino-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-6-yl)phenyl]cyclohexyl]acetic acid | IC50 | 60.0 [1], 71.0 [2] |
| 2-[4-[4-[[5-[(4-Methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 142.0 [1], 728.0 [2] |
| 2-[4-[4-[[5-(2-Cyclopentylethyl)-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 12.0 [1], 19.0 [2] |
| 2-[4-[4-[[5-(Phenoxymethyl)-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 47.0 [1], 107.0 [2] |
| 2-[4-[4-[(5-Phenyl-1,3,4-thiadiazol-2-yl)carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 85.0 [1], 588.0 [2] |
| 4-[5-[(5-Benzyl-1,3,4-thiadiazol-2-yl)carbamoyl]pyridin-2-yl]oxycyclohexane-1-carboxylic acid | IC50 | 45.0 [1], 135.0 [2] |
| 4-[5-[[5-[(3-Chlorophenyl)methyl]-1,3,4-thiadiazol-2-yl]carbamoyl]pyridin-2-yl]oxycyclohexane-1-carboxylic acid | IC50 | 55.0 [1], 85.0 [2] |
| 4-[4-[[5-(Cyclopentyloxymethyl)-1,3,4-thiadiazol-2-yl]carbamoyl]phenoxy]cyclohexane-1-carboxylic acid | IC50 | 12.0 [1], 17.0 [2] |
| 4-[4-[[5-(Cyclopentylamino)-1,3,4-thiadiazol-2-yl]carbamoyl]phenoxy]cyclohexane-1-carboxylic acid | IC50 | 9.0 [1], 22.0 [2] |
| 3-[5-[2-Ethyl-4-(phenylcarbamoyl)-2,3-dihydro-1,4-benzoxazin-7-yl]pyridin-2-yl]oxy-2,2-dimethylpropanoic acid | IC50 | 100.0 [1], 131.0 [2] |
| 2,2-Dimethyl-3-(5-(2-methyl-4-(phenylcarbamoyl)quinolin-7-yl)pyridin-2-yloxy)propanoic acid | IC50 | 275.0 [1] |
| Ethyl 6-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-2-morpholin-4-yl-4-phenyl-7-propylpyrrolo[1,2-b]pyridazine-5-carboxylate | IC50 | 19.0 [1], 48.0 [2] |
| Ethyl 6-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-2-morpholin-4-yl-4-phenyl-7-propylpyrrolo[1,2-b]pyridazine-5-carboxylate | IC50 | 30.0 [1], 48.0 [2] |
| Methyl 4-[4-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]phenyl]piperidine-1-carboxylate | IC50 | 84.0 [1], 500.0 [2] |
| Ethyl 6-(3-cyclohexyl-1,2,4-oxadiazol-5-yl)-2-morpholin-4-yl-4-phenyl-7-propylpyrrolo[1,2-b]pyridazine-5-carboxylate | IC50 | 31.0 [1], 56.0 [2] |
| Ethyl 7-(2-hydroxyethyl)-6-[3-(2-hydroxyethyl)-1,2,4-oxadiazol-5-yl]-2-morpholin-4-yl-4-phenylpyrrolo[1,2-b]pyridazine-5-carboxylate | IC50 | 180.0 [1], 260.0 [2] |
| Ethyl 2-morpholin-4-yl-4-phenyl-6-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)-7-propylpyrrolo[1,2-b]pyridazine-5-carboxylate | IC50 | 51.0 [1], 57.0 [2] |
| Ethyl 6-(3-butyl-1,2,4-oxadiazol-5-yl)-2-morpholin-4-yl-4-phenyl-7-propylpyrrolo[1,2-b]pyridazine-5-carboxylate | IC50 | 69.0 [1], 73.0 [2] |
| Ethyl 2-morpholin-4-yl-4-phenyl-6-(3-phenyl-1,2,4-oxadiazol-5-yl)-7-propylpyrrolo[1,2-b]pyridazine-5-carboxylate | IC50 | 180.0 [1], 200.0 [2] |
| Ethyl 2-morpholin-4-yl-4-phenyl-7-propyl-6-(3-pyrrolidin-1-yl-1,2,4-oxadiazol-5-yl)pyrrolo[1,2-b]pyridazine-5-carboxylate | IC50 | 100.0 [1] |
| 2-[4-[4-[(6S)-4-Amino-6,7-dihydro-[1,4]dioxino[2,3-d]pyrimidin-6-yl]phenyl]cyclohexyl]acetic acid | IC50 | 10.0 [1], 34.0 [2] |
| 4-[4-[[3-[(3,5-Difluorophenyl)methyl]-1,2,4-oxadiazol-5-yl]carbamoyl]phenoxy]cyclohexane-1-carboxylic acid | IC50 | 120.0 [1], 310.0 [2] |
| 2-[4-[4-[(6S)-4-Amino-6,7-dihydro-[1,4]dioxino[2,3-d]pyrimidin-6-yl]phenyl]cyclohexyl]acetonitrile | IC50 | 175.0 [1], 249.0 [2] |
| 2-[4-[4-(4-Amino-6-methyl-7H-[1,4]dioxino[2,3-d]pyrimidin-6-yl)phenyl]cyclohexyl]acetic acid | IC50 | 245.0 [1], 735.0 [2] |
| 2-[4-[4-[(6R)-4-Amino-6,7-dihydro-[1,4]dioxino[2,3-d]pyrimidin-6-yl]phenyl]cyclohexyl]acetic acid | IC50 | 18.0 [1], 77.0 [2] |
| 2-[4-[4-[5-[6-(Trifluoromethyl)-1H-benzimidazol-2-yl]pyridin-2-yl]phenyl]cyclohexyl]acetic acid | IC50 | 3.5 [1], 293.0 [2] |
| 2-[4-[4-[5-(6-Chloro-1H-benzimidazol-2-yl)pyridin-2-yl]phenyl]cyclohexyl]acetic acid | IC50 | 1.1 [1], 167.0 [2] |
| 2-[4-[4-[[5-[(3-Fluorophenyl)methyl]-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 30.0 [1], 46.0 [2] |
| 2-[4-[4-[[5-[(2-Fluorophenyl)methyl]-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 35.0 [1], 45.0 [2] |
| 2-[4-[4-[[5-[(3-Chlorophenyl)methyl]-1,3,4-thiadiazol-2-yl]carbamoyl]phenyl]cyclohexyl]acetic acid | IC50 | 30.0 [1], 57.0 [2] |
| 2-[4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)-2-fluorophenyl]cyclohexyl]acetic acid | IC50 | 60.0 [1], 120.0 [2] |
| 2-[4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)-2-chlorophenyl]cyclohexyl]acetic acid | IC50 | 30.0 [1], 70.0 [2] |
| 2-[4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]phenyl]acetic acid | IC50 | 630.96 [1] |
| 2-[4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)-2-chlorophenyl]phenyl]acetic acid | IC50 | 100.0 [1] |
| [4-[4-(4-Amino-7,7-dimethylpyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]cyclohexyl]methanesulfonamide | IC50 | 20.0 [1], 90.0 [2] |
| 7,7-Dimethyl-6-[4-[4-(2H-tetrazol-5-ylmethyl)cyclohexyl]phenyl]pyrimido[4,5-b][1,4]oxazin-4-amine | IC50 | 7.0 [1], 2500.0 [2] |
| 2-[4-[4-(4-Amino-7,7-dimethylpyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]cyclohexyl]acetamide | IC50 | 15.0 [1], 70.0 [2] |
| 2-[4-[4-(4-Amino-2,7,7-trimethylpyrano[2,3-d]pyrimidin-6-yl)phenyl]cyclohexyl]acetic acid | IC50 | 50.0 [1], 1000.0 [2] |
| 3-[4-[4-(4-Amino-7,7-dimethylpyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]cyclohexyl]propanoic acid | IC50 | 6.0 [1], 100.0 [2] |
| 4-[4-(4-Amino-7,7-dimethylpyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]cyclohexan-1-ol | IC50 | 50.0 [1], 180.0 [2] |
| 2-[4-[4-[4-Amino-7,7-dimethyl-2-(trifluoromethyl)pyrimido[4,5-b][1,4]oxazin-6-yl]phenyl]cyclohexyl]acetic acid | IC50 | 5.0 [1], 60.0 [2] |
| 2-[4-[4-(4-Amino-7,7-dimethylpyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]phenyl]acetic acid | IC50 | 6.0 [1], 3000.0 [2] |
| 6-(4-Cyclohexylphenyl)-7,7-dimethylpyrimido[4,5-b][1,4]oxazin-4-amine | IC50 | 60.0 [1], 390.0 [2] |
| 4-[4-(4-Amino-7,7-dimethylpyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]cyclohexane-1-carboxylic acid | IC50 | 10.0 [1], 120.0 [2] |
| 6-[4-(4,4-Difluorocyclohexyl)phenyl]-7,7-dimethylpyrimido[4,5-b][1,4]oxazin-4-amine | IC50 | 60.0 [1], 470.0 [2] |
| 4-Amino-6-[4-[4-(2H-tetrazol-5-ylmethyl)cyclohexyl]phenyl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one | IC50 | 76.0 [1], 774.0 [2] |
| 2-[4-[4-[(8R)-4-Amino-8-methyl-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6-yl]phenyl]cyclohexyl]acetic acid | IC50 | 8.0 [1], 19.0 [2] |
| 4-Amino-6-[4-[4-(2-hydroxy-2-methylpropyl)cyclohexyl]phenyl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one | IC50 | 25.0 [1], 54.0 [2] |
| 4-Amino-6-[4-[4-(2-amino-2-methylpropyl)cyclohexyl]phenyl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one | IC50 | 40.0 [1], 70.0 [2] |
| 4-Amino-6-[4-[4-(2-oxo-2-pyrrolidin-1-ylethyl)cyclohexyl]phenyl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one | IC50 | 45.0 [1], 110.0 [2] |
| 4-Amino-6-[4-[4-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]cyclohexyl]phenyl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one | IC50 | 23.0 [1], 60.0 [2] |